The Center faculty come from all four UCSF schools and conduct research and teaching in every aspect of tobacco control, from efforts by the tobacco industry to manipulate international politics to the molecular biology of nicotine addiction.


Esteban G. Burchard, MD, MPH


The overall goal of my research group is to identify and characterize genetic, environmental and social factors that predispose to asthma and modify drug response (pharmacogenetics). In addition, we are interested in how racially-specific genetic diffs. modify disease and response to treatment. My major scientific interests center on identifying genetic risk factors for common diseases and traits (e.g. asthma and drug response) in racial/ethnically mixed populations. I am fascinated with how racial/ethnic background influences health and risk of disease.

Nicholas Butowski, MD

Neurological Surgery

We studied whether synthetic CBD (from Insys) could control brain tumors in a mouse model; results were unclear and Insys was not able to provide further support for more studies.  At present, we also are studying how our patient population uses CBD and THC and why and whether it may impact survival. This project is  entitled Impact of Cannabis and Synthetic Cannabinoid Use on Quality of Life in Patients with Central Nervous System Tumors (ICANCNS-QOL)

Amy Byers, PhD, MPH

Assoc. Professor In Residence

Dr. Byers is Professor of Psychiatry & Behavioral Sciences with a joint appointment in the Department of Medicine, Division of Geriatrics. She is an epidemiologist with a background in aging research, methods, and biostatistics. Her research focuses on the epidemiology of late-life mental health and employs advanced epidemiological and biostatistical techniques to determine the incidence, prevalence, risk factors, and outcomes of late-life mental health disorders with the objective of reducing the burden of these disorders by informing long-term clinical care. Dr.

Carolyn Calfee, MD


Research focuses on the effects of active and passive smoking on susceptibility to acute lung injury, a major cause of respiratory failure in critically ill patients. In addition, she is interested in the use of biomarkers to measure cigarette smoke exposure.

Timothy Carmody, PhD


Dr. Carmody's work focuses on the treatment of nicotine dependence in adult chronic smokers. Dr. Carmody has several professional interests in the field of behavioral medicine, including treatment of nicotine dependence, chronic pain, behavioral factors in coronary heart disease, and obesity/weight management.  His primary interest is in the treatment of nicotine dependence in adult chronic smokers. 

Janine Cataldo, RN, PhD, FAAN

Physiological Nursing

Dr. Cataldo's research and clinical foci include: older adults’ risk perceptions of conventional, new and emerging  tobacco  products, and e- cigarettes, how these perceptions are affected by pro- and anti-tobacco messages; the impact of tobacco industry activities on older smokers and geriatric science; lung cancer stigma, symptom burden, and quality of life; and use of virtual worlds as an mHealth intervention to decrease lung cancer stigma and improve patient-clinician communication. Dr.

Benjamin Chaffee, DDS, MPH, PhD

Assistant Professor
Preventive & Restor Dent Sci

The overarching goal of our team’s epidemiologic research program is to understand how various behaviors, biological attributes, and social circumstances influence health and disease distributions, often inequitably, across populations. Application of such knowledge aims to inform future public health practices, health policies, and clinical guidelines that elevate the health of patients and vulnerable communities.

Jing Cheng, MD, MS, PhD

Preventive & Restor Dent Sci

Dr. Cheng is Professor of Biostatistics within the UCSF Division of Oral Epidemiology & Dental Public Health and Division of Epidemiology and Biostatistics, and a faculty member in the UCSF Center to Address Disparities in Oral Health (CAN DO), Tobacco Center of Regulatory Science (TCORS), Helen Diller Family Comprehensive Cancer Center, and Clinical & Transnational Science Institute (CTSI). Dr. Cheng is a well-known biostatistician and 2019 Chair-Elected of the American Statistical Association Section on Statistics in Epidemiology. Dr.

Beth Cohen, MD, MA


Dr. Cohen is an internist and clinical investigator whose research focuses on health outcomes in patients with posttraumatic stress disorder. She is Principal Investigator of the Mind Your Heart Study, a prospective cohort study designed to examine the effects of posttraumatic stress disorder on cardiovascular health.

Robin Corelli, PharmD

Clinical Pharmacy

Primary interest in tobacco cessation education and training. Dr. Corelli has co-coordinated, with other Tobacco Center members (Drs. Hudmon and Kroon), a comprehensive tobacco cessation training program, Rx for Change: Clinician-Assisted Tobacco Cessation, for students in the health professions.

Eric Crosbie, PhD

Postdoctoral Scholar
Cardiovascular Research Inst

Eric Crosbie recently received his PhD in Politics at the University of California, Santa Cruz (UCSC).

Kevin Delucchi, PhD


Dr. Delucchi is a quantitative expert specializing in psycho-social research. Dr. Delucchi's work focuses on statistical methods for analysis of quantitative data including clinical trials of treatments for smoking cessation. He has collaborated with numerous investigators on nicotine-related research and is a member of an NIH Study Section.